Clinical Trial Update: Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating buprenorphine/naloxone for treatment of opioid use disorder (opiate dependence).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED